Literature DB >> 3487743

HLA-A2 as a possible marker for early-onset Alzheimer disease in men.

G W Small, S S Matsuyama.   

Abstract

We performed HLA typing on 36 patients with clinically diagnosed Alzheimer disease and 25 controls. Antigen A2 was present in all ten men (100%) with early-onset (less than 60 years) dementia, a frequency significantly higher than the 30% frequency found in the cognitively intact men of a comparable age (p = 0.009, corrected). This increased A2 frequency was also significantly greater than the frequencies for all other patient subgroups, including late-onset men (40%, p = 0.008), early-onset women (44%, p = 0.004), and late-onset women (42%, p = 0.028). Our findings, if repeated in future studies with larger samples, suggest that HLA-A2 positive men may comprise a subgroup with increased susceptibility to early-onset disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3487743     DOI: 10.1016/0197-4580(86)90045-x

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  2 in total

1.  Evidence for familial factors that protect against dementia and outweigh the effect of increasing age.

Authors:  H Payami; K Montee; J Kaye
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

2.  Alzheimer's disease and HLA-A2: linking neurodegenerative to immune processes through an in silico approach.

Authors:  Ricardo A Cifuentes; Juan Murillo-Rojas
Journal:  Biomed Res Int       Date:  2014-08-17       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.